Drug Type Small molecule drug |
Synonyms WXSH0024 |
Target |
Mechanism AT2R antagonists(Angiotensin II receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Phase 1 | CN | 06 Jul 2022 |